Your browser doesn't support javascript.
loading
The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma.
Mauseth, Brynjar; Camilio, Ketil André; Shi, Jihua; Hammarström, Clara Louise; Rekdal, Øystein; Sveinbjørnsson, Baldur; Line, Pål-Dag.
Afiliação
  • Mauseth B; Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.
  • Camilio KA; Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, 0424 Oslo, Norway.
  • Shi J; Lytix Biopharma, 0275 Oslo, Norway.
  • Hammarström CL; Institute for Cancer Research, Department of Tumor Biology, Oslo University Hospital, 0424 Oslo, Norway.
  • Rekdal Ø; Lytix Biopharma, 0275 Oslo, Norway.
  • Sveinbjørnsson B; Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, 0424 Oslo, Norway.
  • Line PD; Department of Pathology, Oslo University Hospital, 0424 Oslo, Norway.
Mol Ther Oncolytics ; 14: 139-148, 2019 Sep 27.
Article em En | MEDLINE | ID: mdl-31211244
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega